A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

UnitedHealth Group, Boston Scientific, Medtronic and the University of Minnesota Work to Deploy 3,000 Emergency Ventilator Alternative Devices

UnitedHealth Group is collaborating with Boston Scientific, Medtronic and the University of Minnesota to deploy 3,000 newly invented “light” ventilators to address the limited stock of critical breathing support equipment in response to COVID-19.

UnitedHealth Group advises the collaboration went from concept stage to manufacturing in less than 30 days, with the first 500 products ready to ship this week. UnitedHealth Group is working with Medtronic and the University of Minnesota to determine initial destinations, while Boston Scientific is manufacturing and shipping the product.

These innovative devices will help address a clinical gap for patients who need a higher level of respiratory support but don’t have immediate access to traditional ventilators when there is a shortage. They will also provide health care workers with an additional tool to care for high volumes of patients who require emergency breathing support.

“We are grateful for collaborations with distinguished experts in academia, across health care and in other industries to offer innovative solutions like this light ventilator,” said Ken Ehlert, chief scientific officer, UnitedHealth Group. “Unique partnerships will be critical as we work together to confront COVID-19 in the months ahead. These light ventilators will help prevent future ventilation shortages, support patients who need this level of breathing assistance and expand clinical capacity to deliver care.”

The University of Minnesota Medical School and Earl E. Bakken Medical Devices Center initially conceived the idea of the light ventilator, called the Coventor. Boston Scientific, Medtronic and UnitedHealth Group provided technical, clinical, regulatory and manufacturing expertise to refine how the device works and bring it to market at scale.

“We are appreciative of the support locally and nationally in getting the Coventor to the field,” said Stephen Richardson, M.D., cardiac anesthesiology fellow at the University of Minnesota Medical School. “We developed the Coventor to be useful in those clinical settings where traditional ventilators are not available. This allows patients who wouldn’t otherwise have the opportunity to survive, to survive. Making the emergency ventilator alternative devices as fast as possible, pushing it to people everywhere — that’s what this is all about.”

The emergency ventilator alternative device uses an electrically powered robotic arm to mechanically compress an off-the-shelf adult resuscitation bag, the sort often used by paramedics to help a patient breathe. This design provides oxygen assistance and enables health care workers to shift from manually operating the resuscitation bag. The device can also be configured with airflow accessories in multiple ways to best accommodate on-the-ground needs at different clinical facilities.

The devices will be shipped to geographies where ventilators are urgently needed, and any remaining devices will be offered as a donation to the U.S. Strategic National Stockpile. Collaborating to deploy the emergency ventilator alternative is the latest of several initiatives announced by UnitedHealth Group to combat COVID-19. Other initiatives to date include:

  • Investing nearly $70 million to help at-risk populations and protect the health care workforce.
  • Pioneering self-administered swab procedures to expand COVID-19 testing, reduce needed personal protective equipment and protect health care workers from unnecessary exposure to COVID-19.
  • Accelerating payments to providers throughout the crisis, with an initial tranche of nearly $2 billion.
  • Waiving cost-sharing for COVID-19 testing and treatment for U.S. members of UnitedHealthcare plans and simplifying access to care by reducing prior-authorization requirements.
  • Significantly expanding access to telehealth and virtual visits and redeploying 5,000 Optum clinicians to expand telehealth capabilities.
  • Providing a special enrollment period for fully insured customers to allow employees who did not opt-in for coverage during the regular enrollment period to secure coverage.
  • Conducting proactive personal outreach to support seniors and the most vulnerable populations among our members.
  • Launching a free nationwide emotional-support line to manage the stress and anxiety caused by COVID-19.
  • Converting company cafeterias to provide more than 75,000 meals a week for people in need and keeping our cafe team at work.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy